The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Atea Pharmaceuticals | Common Stock | 04683R106 | 16,043 | 746,868 | SH | SOLE | 746,868 | 0 | 0 | ||
Arcutis Biothereapeutics | Common Stock | 03969K108 | 17,024 | 623,836 | SH | SOLE | 623,836 | 0 | 0 | ||
Alpine Immune Sciences | Common Stock | 02083G100 | 11,564 | 1,284,900 | SH | SOLE | 1,284,900 | 0 | 0 | ||
Checkmate Pharmaceuticals | Common Stock | 162818108 | 7,957 | 1,335,050 | SH | SOLE | 1,335,050 | 0 | 0 | ||
Cidara Therapeutics | Common Stock | 171757107 | 4,051 | 2,005,249 | SH | SOLE | 2,005,249 | 0 | 0 | ||
ESSA Pharma | Common Stock | 29668H708 | 9,377 | 328,196 | SH | SOLE | 328,196 | 0 | 0 | ||
FibroGen | Common Stock | 31572Q808 | 3,479 | 130,646 | SH | SOLE | 130,646 | 0 | 0 | ||
Gossamer Bio | Common Stock | 38341P102 | 26,963 | 3,320,608 | SH | SOLE | 3,320,608 | 0 | 0 | ||
Ikena Oncology | Common Stock | 45175G108 | 31,578 | 2,249,123 | SH | SOLE | 2,249,123 | 0 | 0 | ||
Immunic | Common Stock | 4525EP101 | 21,923 | 1,788,160 | SH | SOLE | 1,788,160 | 0 | 0 | ||
Immunocore Holdings | Common Stock | 45258D105 | 2,012 | 51,535 | SH | SOLE | 51,535 | 0 | 0 | ||
Jounce Therapeutics | Common Stock | 481116101 | 1,873 | 275,513 | SH | SOLE | 275,513 | 0 | 0 | ||
Kronos Bio | Common Stock | 50107A104 | 91,448 | 3,818,283 | SH | SOLE | 3,818,283 | 0 | 0 | ||
Morphic Holding | Common Stock | 61775R105 | 101,428 | 1,767,350 | SH | SOLE | 1,767,350 | 0 | 0 | ||
ObsEva | Common Stock | H5861P103 | 3,028 | 999,364 | SH | SOLE | 999,364 | 0 | 0 | ||
Omega Alpha SPAC | Common Stock | G6749V107 | 4,985 | 501,000 | SH | SOLE | 501,000 | 0 | 0 | ||
Paratek Pharmaceuticals | Common Stock | 699374302 | 17,735 | 2,600,410 | SH | SOLE | 2,600,410 | 0 | 0 | ||
Replimune Group | Common Stock | 76029N106 | 192,417 | 5,008,245 | SH | SOLE | 5,008,245 | 0 | 0 | ||
Spruce Biosciences | Common Stock | 85209E109 | 24,225 | 2,161,022 | SH | SOLE | 2,161,022 | 0 | 0 | ||
Syros Pharmaceuticals | Common Stock | 87184Q107 | 12,398 | 2,274,831 | SH | SOLE | 2,274,831 | 0 | 0 | ||
Trevi Therapeutics | Common Stock | 89532M101 | 2,843 | 1,263,408 | SH | SOLE | 1,263,408 | 0 | 0 |